Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. (CAPR) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CAPR · as of Jun 30, 2024
Ownership Breakdown
68
Institutional Holders
▲ 5 vs Q1
$30.65M
Total Inst. Value
▼ $2.06M vs Q1
45.72M
Shares Outstanding
freeFloat 82.69%
6.43M
13F Shares Held
▲ 1.61M vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CAPR largest shareholders · institutional ownership
Q2 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK INC. pharmaceutical preparations | 1.63M | 5.11% | 5.11% | $7.77B | Aug 13, 2024 | ▲ 1.25M |
VANGUARD GROUP INC pharmaceutical preparations | 1.55M | 4.86% | 4.86% | $7.39B | Aug 13, 2024 | ▲ 183.0K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 641.6K | 2.01% | 2.01% | $3.06B | Aug 9, 2024 | ▲ 313.1K |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 479.5K | 1.51% | 1.51% | $2.29B | Aug 14, 2024 | ▲ 186.5K |
STATE STREET CORP pharmaceutical preparations | 401.0K | 1.26% | 1.26% | $1.91B | Aug 14, 2024 | ▲ 284.3K |
CAPTION MANAGEMENT, LLC pharmaceutical preparations | 305.7K | 96.01% | 96.01% | $1.46B | Aug 14, 2024 | NEW |
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 162.3K | 50.97% | 50.97% | $774.17M | Aug 13, 2024 | ▲ 4.1K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 137.5K | 43.18% | 43.18% | $655.88M | Aug 9, 2024 | ▲ 84.3K |
CAPTION MANAGEMENT, LLC pharmaceutical preparations | 130.5K | 40.98% | 40.98% | $622.49M | Aug 14, 2024 | NEW |
NORTHERN TRUST CORP pharmaceutical preparations | 129.6K | 40.71% | 40.71% | $618.25M | Aug 14, 2024 | ▲ 9.3K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2024 vs prior quarter
Q2 2024
18
Increased
+2.52M shares15
New Positions
first time holders16
Decreased
−809.5K shares0
Sold Out
fully exitedNet shares change (top 50)
+1.71M
+2.52M / −809.5K
Net new holders
+17
15 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CAPR insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
6
Buy transactions
10
Sell transactions
0.60
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Maurer Michael T CHIEF COMMERCIAL OFFICER | May 26, 2026 | Award | 80,000 | $29.36 | $2.35M | 80.0K | Form 4 ↗ |
Krasney Karen EVP, GENERAL COUNSEL | May 1, 2026 | Sale | 25,000 | $31.70 | $792.5K | 30.5K | Form 4 ↗ |
Bergmann Anthony CHIEF FINANCIAL OFFICER | May 1, 2026 | Sale | 25,000 | $31.70 | $792.5K | 8.2K | Form 4 ↗ |
Sabar Karimah Es director | Apr 2, 2026 | Sale | 7,529 | $32.00 | $240.9K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Capricor Therapeutics, Inc. (CAPR) is primarily owned by institutional investors, who hold approximately 14.1% of total shares outstanding. Company insiders own approximately 17.31%, while retail and public investors account for the remaining 68.64%.
The largest institutional shareholder of Capricor Therapeutics, Inc. is BLACKROCK INC., holding approximately 1.63 million shares — equal to 5.11% of outstanding shares — as of June 30, 2024.
A total of 68 institutional investors currently hold CAPR stock, with a combined institutional value of approximately $30,651,395 as of the most recent 13F filing period.
Frequently asked questions
CAPR ownershipCapricor Therapeutics, Inc. (CAPR) is primarily owned by institutional investors, who hold approximately 14.1% of shares. The largest shareholder is BLACKROCK INC. with a 5.11% stake. Company insiders hold 17.31%. Data sourced from SEC Form 13F as of June 30, 2024.